Neuroscience has been an area of focus for Technology Partners since the early 1990's. We invest in biotech, biopharma and medical device companies in the neurotechnology industry. Our investments include seeding companies, such as the spinout of Rinat Neuroscience from Genentech, through later rounds of more developed companies.
Neurotechnology
Portfolio
BrainCells, Inc.
BrainCells is developing novel therapies for affective and cognitive disorders based on proprietary neurogenesis technology.
Cadence (NASDAQ: CADX)
Cadence Pharmaceuticals is a specialty pharmaceutical company focused on the hospital market. A key program is the management of peri-operative pain.
Cardax Pharmaceuticals is developing proprietary drugs to reduce oxidative stress and inflammation. The lead compound is focused on preventing neurological damage and rethrombosis in stroke patients.
Ekos
Ekos develops ultrasound-enabled drug delivery devices for the treatment of stroke and peripheral applications.
Innercool Therapies Acquired by Cardium Therapeutics Innercool Therapies is the leader in therapeutic hypothermia devices to protect the brain from further injury following stroke, cardiac arrrest or brain surgery.
Leptos Biomedical
Leptos Biomedical is developing a proprietary neuromodulation therapy for obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system.
NeuraLieve
Neuralieve is developing a hand-held device to treat migraine headache. Neuralieve's core technology is based on the science of transcranial magnetic stimulation (TMS).
NeuroPace
NeuroPace is developing fully- implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy.
Nfocus Neuromedical, Inc.
NFocus is developing novel neurovascular devices for the treatment of cerebral aneurysms and hemorrhagic stroke.
PercuSurge Acquired by Medtronic Inc. (NYSE: MDT)
Percusurge was the pioneer in developing emboli-protection devices for the prevention of stoke and heart attack.
Rinat Neuroscience Acquired by Pfizer Inc. (NYSE: PFE) Rinat is developing novel therapies based on anti-body technology for the treat of CNS disorders.
Saegis Pharmaceuticals Acquired by Lundbeck Pharmaceuticals(OMX:LUN)
Saegis develops therapies for the treatment of Alzheimer's Disease and other memory disorders.
Spinal Dynamics Acquired by Medtronic Inc. (NYSE: MDT)
Spinal Dynamics develops neuro-surgical devices for the replacement of spinal disks.
Latest News and
Events
Roger Quy to speak at The Neurotech Industry Investing & Partnering Conference:
